SEC Filing Summary

Marc Whitten, President and CEO of Dolby Laboratories, Inc., was granted 160,256 restricted stock units (RSUs) under the 2026 Inducement Stock Plan on September 15, 2026. These RSUs vest quarterly starting March 15, 2027, subject to continued employment. Additionally, Whitten received 600,000 performance-based RSUs under the same plan. These performance-based RSUs are divided into five tranches, vesting upon achieving stock price hurdles of $75, $100, $125, $150, and $175, respectively, within a five-year period, also contingent on continued employment. Shares held post-transaction include 160,256 shares of Class A common stock underlying RSUs, which are subject to forfeiture until vested. All transactions were reported on Form 4, filed on September 17, 2026.